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Abstract 
 E2f7 and E2f8 are the most recently discovered members of the E2f family of 
transcription factors.  The conventional knockout of either E2f7 or E2f8 in mice results in 
no observable phenotype.  However, the concomitant loss of both genes results in 
massive apoptosis and dilation of blood vessels in the embryo and abnormal clustering of 
trophoblast cells in the placenta, leading to embryonic lethality at day 11.5 (E11.5).   This 
indicated that the E2F7 and E2F8 proteins are functionally redundant and critical for 
embryonic viability at mid-gestation.  Until recently however, the tissues, cellular 
processes, and molecular pathways regulated by these two proteins remained unknown.  
Here, we use a conditional knockout strategy to show that the extra-embryonic functions 
of E2F7 and E2F8 are both necessary and sufficient for embryonic viability at mid-
gestation.  Furthermore, we have defined a role for E2F7 and E2F8 in controlling the 
G1/S transition.  This led us to the discovery of an important genetic interaction between 
E2F7/E2F8 and E2F3a, critical for regulating the G1/S transition and maintaining 
embryonic viability.  In summary, we identified a novel transcriptional network shared by 
E2F3a, E2F7 and E2F8 that is critical for control of cell proliferation, placental 
development and fetal viability.   
 
 
 
 
 
  
Introduction 
 In response to an external growth stimulus, most cells will initiate a signaling 
cascade that will result in a proper and ordered cell cycle, culminating in the division of 
one cell into two identical daughter cells.  A critical step in the entry into an active cell 
cycle involves the downregulation of Cyclin dependant kinase (Cdk) inhibitors, the 
induction of G1 Cyclins, and the resulting association between Cyclins and their catalytic 
subunits (Murray, 2004; Sánchez and Dynlacht, 2005).  These events eventually lead to 
the activation of Cdk complexes and the phosphorylation of Retinoblastoma (Rb) and its 
associated pocket protein family members p107 and p130.  This phosphorylation results 
in the dissociation of pocket protein-E2f repressor complexes to promote E2f dependent 
transcription and the activation of E2f-dependent genes (Frolov and Dyson, 2004).  
Accumulation of E2f-dependent gene activity in late G1 is believed to represent the final 
step in CDK-dependent signaling that irreversibly commits the cell to begin DNA 
replication.  The high level of E2f-dependent transcription is then cut off in late S phase 
by a second wave of E2f-mediated repression that marks the end of DNA replication and 
pushes the cell into G2.  Therefore, through sequential waves of G0-repression, G1-S 
activation and S-G2 repression, the E2f family of transcription factors is able to 
orchestrate proper progression through the cell cycle. 
 The mammalian E2f family consists of eight genes (E2F1-8) (Figure 1).  
Structure-function studies classify these eight genes are divided into an activator subclass 
and a repressor subclass.  E2F1, E2F2, and E2F3a make up the activator subclass, due to 
their strong transcription activation domains, with an Rb binding site buried within this 
region (Cam and Dynlacht, 2003).  During G0, the activation domain is held inactive by 
  
the binding of Rb in this region.  E2F1-3 are expressed at their peak levels during the 
G1/S transition, indicating their crucial role in initiating DNA replication.  E2F3b, E2F4, 
E2F5, E2F6, E2F7, and E2F8 constitute the repressor subclass of the E2F family.  E2F4 
and E2F5 are the critical E2F’s at the G0 checkpoint, serving to recruit pocket proteins, 
and other co-repressors to target promoters (Attwooll et al., 2004).  The repression of 
their target genes is critical for holding the cell in a quiescent state.  MEFs deficient for 
E2f4 and E2f5 do not repress G0-specific targets and fail to proliferate in response to 
mitogenic signals (Gaubatz et al., 2000).  E2F6, E2F7, and E2F8 are expressed at their 
peak levels during G2/S, marking the end of DNA replication.  They represent the only 
group of the E2F family lacking an Rb-binding domain, suggesting that they repress gene 
expression in a pocket protein-independent manner.  E2F6 binds its targets as a member 
of a large, multi-subunit repressor that includes the polycomb proteins along with Mga 
and Max (Ogawa et al., 2002).  The mechanism through which E2F7 and E2F8 bind to 
and repress target genes, on the other hand, is far less understood due to their recent 
discovery and lack of characterization. 
 E2F7 and E2F8 exhibit several structural characteristics that set them apart from 
the rest of the E2F family.  As mentioned above, E2F7 and E2F8 lack the Rb-binding 
domain as well as the Marked Box (Mark.), which is involved in mediating interactions 
with cofactors (Figure 1).  These two new E2Fs also lack the characteristic leucine-zipper 
domain that is required for dimerization with the partner proteins DP1/2.  However, they 
possess two tandem DNA-binding domains (DBD) which allow them to bind DNA in a 
DP-independent manner (de Bruin et al., 2003; Di Stefano et al., 2003; Logan et al., 
2004; Christensen et al., 2005; Logan et al., 2005; Maiti et al., 2005).  These distinctive 
  
structural features indicate that E2F7 and E2F8 function as a unique arm of the E2F 
family. 
 Previous work has shown that the individual deletion of E2f7 or E2f8 in mice 
results in no observable phenotypes.  However, embryos lacking both E2f7 and E2f8 
exhibit widespread apoptosis and die by embryonic day 11.5 (E11.5) (Li et al., 2008). 
The apoptosis was shown to be E2F1 and p53 dependent, as the concomitant loss of 
either E2f1 or p53 suppressed the ectopic apoptosis.  However, these embryos still died 
by E11.5, indicating that fetal apoptosis was not the cause of death.  The tissues, 
molecular pathways, and cellular processes disrupted in E2f7-/-/E2f8-/- (Double knockout, 
DKO) embryos that led to their lethality remain completely unknown.  In this study, we 
aim to directly address these questions and further characterize the function of E2F7 and 
E2F8.  Utilizing a conditional knockout system, we demonstrate that the function of 
E2F7 and E2F8 in the placenta is both necessary and sufficient to carry the embryo to 
term.  We also show that the critical action of E2F7/E2F8 involves regulating the G1/S 
transition, involving a critical interaction with E2F3a.  In conclusion, we demonstrate 
throughout this study that the repressive function of E2F7 and E2F8 is critical for the 
control of cell cycle progression. 
 
Materials and Methods  
Mouse Strains and Genotyping.   
The conventional and conditional E2f7, E2f8 knockout mice, Sox2-cre, Cyp19-cre 
transgenic mice, and Rosa26 reporter mice were maintained on a mixed 129SvEv; 
C57B/L6; FVB background.  Three allele-specific primers were used for E2f7 and E2f8 
  
PCR genotyping: E2F7-a, 5’-AGGCAGCACACTTGACACG-3’;    E2F7-b, 5’-
ACTTTTGGGACAGAGGGTAGGA-3’;       E2F7-c, 5’-
CCAAGATGAAGGCCGAGATGCTAC-3’;      or E2F8-a, 5-
TAAAAAGCTTTGCGGTCGTT-3’;     E2F8-b, 5’-AAGCCAACCTCGATCAATTG-3’;    
E2F8-c, 5-CTCGCATCATCGTCTGCT-3’ 
 
Quantitative RT-PCR (qRT-PCR) 
Total RNA was extracted using Qiagen RNA miniprep columns according to the 
manufacturer’s protocol, which included the optional DNase treatment before elution 
from the column.  Reverse transcription of total RNA was performed using Superscript 
III reverse transcriptase (Invitrogen) and RNAse Inhibitor (Roche) as described by the 
manufacturer.  Quantitative PCR was performed using SYBR Green reaction mix 
(BioRad) and the BioRad iCycler PCR machine.  All reactions were performed in 
triplicate and relative amounts of cDNA were normalized to Gapdh.  Primer sequences 
are available upon request. 
 
In situ Hybridization 
In situ hybridization was performed on E9.5 (Proliferin) and E10.5 (Tpbp) placenta 
sections using a previously reported protocol (Christensen et al., 2002) that was modified 
for paraffin-embedded sections.  These modifications were deparaffinization in xylene 
and Proteinase K (1 µg/ml) digestion.  Plasmids for Proliferin and Tpbp (gifts from Dr. J. 
Rossant) were linearized with HindIII and XbaI, respectively, to generate templates for 
riboprobe synthesis.  Radiolabeled probes were generated by in vitro transcription with 
  
either T7 (Proliferin) or T3 (Tpbp) RNA polymerase (Roche) using both 35S-CTP and 
35S-UTP.  The probes were hydrolyzed at 60°C for 20 minutes in bicarbonate buffer (80 
mM NaHCO3, 120 mM Na2CO3).  Hybridizations were performed with 1x107 dpm/slide 
for each probe.  Following application of the autoradiography emulsion NTB (Kodak), 
the slides were exposed for 1 day (Proliferin) or 3 days (Tpbp) before the emulsion was 
developed. 
 
Histological Analysis and Immunostaining  
Placenta samples were fixed in 10% neutral buffered formalin and embedded in paraffin.  
5µm-thick sections were prepared.  Standard hematoxylin and eosin (H&E) staining was 
used for general histopathological analysis.  For immunostaining, slides were probed with 
primary antibodies specifically against E2F7 (ab56022, Abcam), E2F8 (homemade 
polyclonal antibody raised against a peptide representing amino acids 576-595 of murine 
E2F8), and Phospho-Histone 3 (P-H3, Ser10) (06-570, Millipore).  Vectastain Elite ABC 
reagent (Vector labs) and DAB peroxidase substrate kit (Vector labs) were used in 
combination to immunohistochemically detect E2F7, E2F8, and P-H3 signals by 
following the manufacturer’s instructions.  Samples were counterstained with 
hematoxylin.   
Cells under M phase of cell cycle and/or belonging to giant cell lineage were 
detected by immunofluorescence (IF) staining using P-H3 and PL-1 antibodies.  Giant 
cells under G1/S transition of endocycle were detected by double IF staining using BrdU 
(MO-0744, DAKO) and PL-1 (A gift from Dr. F Talamantes) antibodies.  Nuclear DNA 
was counterstained with DAPI.   
  
 
 
 
BrdU Assay 
Pregnant females at 10.5 days postcoitum were injected intraperitoneally with BrdU (100 
µg/grams of body weight) 30 min prior to harvesting.  Samples were fixed in formalin 
and 5µm paraffin embedded-sections were used.  After deparaffinization, anti-BrdU 
antibodies were used to detect BrdU incorporation according to the manufacturer’s 
instructions.  BrdU-stained slides were counterstained with DAPI and hematoxylin, 
respectively. 
 
Affymetrix Microarray Analysis 
Total RNA was isolated using Qiagen RNA miniprep columns according to the 
manufacturer’s protocol.  Global gene expression analyses were performed on 
Affymetrix Mouse Genome 430 2.0 arrays at the Ohio State University Comprehensive 
Cancer Center (www.osuccc.osu.edu/microarray/).  Expression values were adjusted by 
quantile normalization and log2 transformation with RMAExpress and data was analyzed 
with BRB-ArrayTools 3.7.0 (http: linus.nci.nih.gov BRB-ArrayTools.html).  Class 
comparison was used to select genes differentially expressed at a significance level of 
p<0.05.  Probes with a >2-fold misexpression in E2f7-/-;E2f8-/- when compared to 
E2f7+/+;E2f8+/+ were used and the average relative expression level of each genetic group 
was loaded into the TIGR MultiExperiment Viewer (MEV, version 4.0) (TIGR, 
Rockville, MD) to generate heatmaps.  Clustering and scatter plot analyses were 
  
performed by using Clustering and Scatterplot functions on BRB Array Tools.  Promoter 
sequences of each gene (-1000bp ~ +300bp) were obtained from UCSC genome browser 
(http://genome.ucsc.edu/).  TFSearch (http://www.cbrc.jp/research/db/TFSEARCH.html) 
aided in the identification of genes containing E2F consensus binding sites.   
 
Chromatin Immunoprecipitation (ChIP)  
For ChIP assays, the EZ CHIPTM assay kit (Upstate Biotech) was used as described by 
the manufacturer.  Briefly, HEK 293 cells overexpressing flag-E2F7, flag-E2F8 wild type 
or flag-E2F7DBD1-2, flag-E2F8DBD1-2 DNA binding mutant forms were crosslinked, 
lysed and sonicated followed by incubation with 2µg of anti-flag (M2, Sigma) or normal 
mouse IgG (Oncogene) antibodies at 4°C overnight.  Antibody-protein-DNA complexes 
were recovered by addition of 30µl of Salmon Sperm DNA/Protein G agarose slurry 
(Upstate Biotech).  Immunoprecipitated DNA fractions were decrosslinked and purified 
through Qiaquick columns (Qiagen).  Real-time PCR quantification of ChIP samples was 
performed using the Biorad iCycler machine with primers specific for the indicated 
promoter regions.  Reactions were performed in triplicate and normalized using the 
threshold cycle number for the total input sample.  Sequences of primers are available 
upon request. 
 
Confocal Microscopy and 3D Reconstruction  
Placenta samples were collected from E10.5 mutant and control embryos, fixed with 4% 
paraformaldehyde overnight at 4°C and embedded in OCT.  70µm-thick frozen sections 
were cut, washed with 0.2% Triton-X in PBS for 1.5 hours and stained with 1mM Draq5 
  
(Biostatus) at 4°C overnight.  Draq5-stained samples were examined by confocal laser 
scanning microscopy (Zeiss LSM 510) with the use of a 63X objective and 0.7X scan 
zoom.  Optical sections with between-plane-plane resolution of 0.40µm and axial 
resolution of 0.42µm were acquired.  Four to five separate regions were imaged with a 
field of view of 207µm x 207µm and depth of 40 ± 2µm resulting in a stack of 100 
images for each region.  For 3D reconstruction, the image stacks were processed using 
Insight Toolkit and ITK-SNAP (Yushkevich et al., 2006).  Each cell nucleus was 
segmented by active contour segmentation using region competition as the stopping 
criterion (Zhu and Yuille, 1996).  Nuclei of binucleated and multinucleated cells were 
constructed separately and assigned different colors. 
 
Transmission Electron Microscopy (TEM) 
E10.5 placentas were harvested and fixed with 3% glutaraldehyde in 0.1M phosphate 
buffer overnight at 4°C.  Following fixation, tissues were processed according to TEM 
Fixation Protocol (http://cmif.osu.edu/419.cfm) and embedded in Eponate resin for TEM 
observations.  Ultrathin cross sections of placenta (70nm) were mounted on copper grids, 
double stained with uranyl acetate and lead citrate, and observed with a Technai G2 Spirit 
transmission electron microscope (FEI).   
 
 
Quantification and Statistical Analysis 
Images of immunostained sections were captured using Eclipse 50i (Nikon) and 
Axioskop 40 (Zeiss) microscopes and quantified using Metamorph Imaging 6.1 software.  
  
Quantification of BrdU-postive cells was achieved by calculating the percentage of 
positive cells in the different regions or in the different cell lineages.  Counting data are 
reported as the average ± SD fold induction of percentage of positive cells.  Three 
sections per sample and at least three different samples for each genotype were analyzed.  
Results were represented as the average ± SD percentage of binucleated cells from three 
different samples.  At least 143 giant cells were counted for each genotype group. 
 
X-gal Staining 
Whole-mount samples or 10µm frozen sections were fixed in 2% formaldehyde and 0.2% 
glutaraldehyde in PBS for 1.5 hours, and then washed 3 times for 5 minutes each in PBS 
at room temperature.  Staining was carried out in 1mg/ml X-gal, 5mM potassium 
ferrocyanide, and 5mM potassium ferricyanide in lacZ wash buffer (0.01% deoxycholate, 
0.02% NP-40 and 2mM MgCl2) at 37°C overnight.  Nuclear Fast Red counterstaining 
was used to visualize lacZ-negative cells from the frozen sections. 
 
Results 
Conventional knockout of E2f7 and E2f8 leads to profound placental defects 
Previous work has shown that E2F7 and E2F8 are critical for mouse embryonic viability 
during mid-gestation, as their combined deletion results in embryonic lethality by day 
11.5 (E11.5) (Li et al, 2008).  This study is focused on further characterizing the 
dysfunction caused by the deletion of E2f7/E2f8 that led to mid-gestation lethality.  We 
reasoned that the identification of the tissues in which E2F7 and E2F8 play a critical role 
  
in maintaining embryo viability would provide valuable insight into their physiological 
and molecular functions. 
 Embryos supplied with a non-functional placenta often show severe growth and 
developmental retardation, sometimes leading to lethality during mid-gestation (Rossant 
and Cross, 2001; Watson and Cross, 2005).  Therefore, we deemed it prudent to further 
investigate placental defects exhibited in E2f7-/-/E2f8-/- mice.  Quantitative RT-PCR 
(qRT-PCR)showed relatively high expression of both E2f7 and E2f8 in the placenta as 
compared to the fetus, indicating that they play a more critical role in extra-embryonic 
cell lineages than in embryonic cell lineages (Figure 2a).  Immunohistochemistry (IHC) 
staining confirmed that E2F7 and E2F8 are highly expressed at the protein level in each 
of the three main cell lineages of the placenta: Trophoblast Giant Cells (TG), 
Spongiotrophoblast (ST), and Labyrinth Trophoblast (LT) (Figure 2b).  The expression of 
E2F7 and E2F8 appeared a bit odd however, as they were expressed highly in some cells 
and not at all in others, which served as a reflection of their cell cycle-dependent 
expression (de Bruin et al., 2003; Di Stefano et al., 2003; Maiti et al., 2005).  We then 
examined Hematoxylin and Eosin (H&E)-stained sections of placenta to assess any gross 
physiological defects that may result in E2f7-/-/E2f8-/- placentas (Figure 3a).  In wild-type 
tissue at E10.5, H&E staining shows well organized tissue, with vasculature arranged as 
maternal sinusoids juxtaposed to fetal-derived blood vessels.  The placental structure in 
E2f7-/-/E2f8-/- embryos, however, was highly disorganized.  These placentas exhibited 
abnormal clustering of trophoblast tissue that failed to invade the maternal decidua as 
well as a poorly developed vasculature network.  Expression levels of cell lineage 
markers also highlighted the importance of E2F7 and E2F8 in tissue differentiation 
  
(Figure 3b).  While certain trophoblast stem cell markers (Eomes and Cdx2) were 
expressed at normal levels in  E2f7-/-/E2f8-/- tissue, the expression of SP and TG specific 
markers (Tpbg, Pgfp; and Proliferin, Csf1r, Pl-1, and Prp, respectively) was greatly 
reduced.  In situ hybridization allowed us to visually confirm the decrease of Tpbp and 
Proliferin in the DKO placenta (Figure 3c and 3d).  From these combined results, we 
were able to confirm that the placenta in E2f7-/-/E2f8-/- embryos exhibits severe structural 
and cellular defects, suggesting that E2F7 and E2F8 play a critical role in the 
differentiation of this tissue during mid-gestation. 
 
Extra-embryonic function of E2F7 and E2F8 is both necessary and sufficient for 
embryonic viability 
Because of the high expression levels of E2F7 and E2F8 in extra-embryonic lineages as 
well as the severe defects observed in the placenta of E2f7-/-/E2f8-/- embryos, we decided 
to more rigorously investigate the roles of E2F7 and E2F8 in the placenta.  By utilizing 
the Cre-LoxP transgenic system, we were able to selectively disrupt E2f7 and E2f8 in a 
tissue-specific manner.  To do this, we bred E2f7LoxP/LoxP/E2f8LoxP/LoxP/Rosa26+/LoxP mice 
to Sox2+/cre mice, generating mice that were E2f7/E2f8 deficient in the embryonic 
compartment, but were supplied with a wild type placenta.  Sox2-cre mice will express 
Cre-recombinase in the embryo proper, but not placenta, as early as E6.5 (Hayashi et al., 
2002).  The Rosa26+/loxp gene served as a reporter gene to allow for visual confirmation of 
Cre-recombinase expression via X-gal staining (Soriano, 1999).  The efficiency and 
specificity of deletion was confirmed first by genotyping a variety of tissues via PCR, 
then visually by performing X-gal staining on E12.5 embryos and at birth (P0 pups) 
  
(Figures 4c and 4d).  Amazingly, these animals were discovered to be alive at all stages 
of embryonic development up until P0, although any pups that did survive through birth 
were severely runted and died shortly thereafter (Figure 4a).  At E10.5, the embryos 
showed none of the obvious phenotypes associated with E2f7-/-/E2f8-/- embryos, 
indicating that the embryo proper is not the critical tissue for E2F7/E2F8 function during 
mid-gestation (Figure 4b).  This also gave us some perspective as to just how important 
the placenta was for E2F7/E2F8 function, as it is able to carry the pregnancy to term. 
 To reconfirm that the placenta is the critical compartment for E2F7/E2F8 
function, we again used the Cre-LoxP transgenic system.  This time we aimed to disrupt 
endogenous E2f7/E2f8 in the placenta by breeding our 
E2f7loxp/loxp/E2f8loxp/loxp/Rosa26+/loxp mice to Cyp19+/loxp mice, resulting in the specific 
deletion of E2f7/E2f8 in extra-embryonic cell lineages. Cyp19-cre mice express Cre-
recombinase by E6.5 in all trophoblast cell lineages, but not in the embryonic 
compartment (Wenzel and Leone, 2007).  The specificity and efficiency of these 
deletions were again confirmed via PCR genotyping of placenta and fetus, as well as X-
gal staining (Figures 5c and 5d).  The results highlight the importance of E2F7 and E2F8 
function in the placenta, as their conditional deletion in the placenta completely 
recapitulated the phenotypes observed in the conventional double knockout embryos.  By 
E10.5, approximately half of the embryos had died, and all were dead by E11.5 (Figure 
5a).  These embryos were developmentally retarded (visibly smaller than wild type) by 
E9.5 (Figure 5b).  Associated with this growth retardation was the disruption of placental 
architecture as seen in E2f7-/-/E2f8-/- mice, as well the dilation of blood vessels in and 
  
around the umbilical cord (Figure 5b).  These genetic analyses provide evidcene  that the 
placenta is the critical compartment for E2F7 and E2F8 function during mid-gestation. 
 
Loss of E2F7 and E2F8 in the placenta dictates molecular events in the fetus 
As both E2F7 and E2F8 act as transcription factors, we assumed that the misregulation of 
its gene targets was likely the underlying reason for many of the severe phenotypes 
observed.  To explore this hypothesis, we used Affymetrix microarrays to compare global 
gene expression in fetal tissue derived from E2f7+/+/E2f8+/+ and E2f7-/-/E2f8-/- mice.  In 
order to discriminate between direct and placenta-induced indirect changes in gene 
expression we also included Sox2+/cre/E2f7-/loxp/E2f8-/loxp (Sox2-cre), and   
Cyp19+/cre/E2f7-/loxp/E2f8-/loxp (Cyp19-cre) embryos as well.  All embryos were harvested 
at day E10.5.  We began by comparing overall expression patterns across the four groups, 
and ended with gene-specific annotation of E2F7/E2F8 direct targets. 
 Unsupervised clustering of the entire set of fetal expression data segregated the 
four genotypic sets into two arms.  E2f7+/+/E2f8+/+ and Sox2-cre fetuses segregated to 
one arm and E2f7-/-/E2f8-/- and Cyp19-cre fetuses segregated to the other (Figure 6).  This 
was remarkable in that fetuses with opposite genotypes segregated together.  In one arm, 
Sox2-cre did segregate from E2f7+/+/E2f8+/+, indicating that the disruption of E2f7 and 
E2f8 in the fetus does result in some cell autonomous gene misexpression.  In the other 
branch however, E2f7-/-/E2f8-/- and Cyp19-cre fail to segregate from one another, despite 
the fact that Cyp19-cre fetuses expressed functional E2F7 and E2F8 and E2f7-/-/E2f8-/- 
fetuses did not.  These results highlight the importance of placental E2F7 and E2F8 in not 
only determining the health and viability of the fetus, but also their molecular readouts.  
  
 
Identification of Direct Targets of E2F7 and E2F8  
We then performed global expression analyses on E2f7+/+/E2f8+/+, E2f7-/-/E2f8-/-, Sox2-
cre and Cyp19-cre E10.5 placentas.  Unsupervised clustering analysis separated the four 
genetic groups into two arms again, with E2f7+/+/E2f8+/+ and Sox2-cre cohorts clustering 
together in one arm and E2f7-/-/E2f8-/- and Cyp19-cre cohorts clustering in the other arm 
(Figure 7a).  As in the analysis for the fetuses, the clustering pattern was based on the 
genotype of the placenta, again highlighting the critical role of placental E2F7 and E2F8 
in determining molecular events.  However, we did observe differences in clustering 
between E2f7+/+/E2f8+/+ and Sox2-cre placentas and between E2f7-/-/E2f8-/- and Cyp19-
cre placentas, indicating that fetal E2F7/E2F8 do have an effect on placental gene 
expression. 
 E2F7 and E2F8 are believed to act as transcriptional repressors.  In order to 
identify direct targets repressed by E2F7/E2F8, we focused on genes that were 
upregulated in tissues lacking E2f7/E2f8.  We analyzed both E2f7-/-/E2f8-/- and Cyp19-cre 
placentas and found a subset of 49 genes that were upregulated >2 fold in both genotypic 
classes (Figure 7b).  We then confirmed these results via qRT-PCR on a subset of the 49 
genes (data not shown).  Characterization of these genes indicated an enrichment of genes 
with functions related to metabolism, placental development, and cell cycle regulation 
(Figure 7c). 
 We then proceeded to determine which, if any, of these 49 genes were also 
upregulated in fetuses lacking E2f7/E2f8.  While we considered the use of both E2f7-/-
/E2f8-/- and Sox2-cre microarrays for this analysis, we decided to only analyze the Sox2-
  
cre array in an effort to avoid non-autonomous gene misregulation in the fetus caused by 
placental defects.  We included all genes whose expression was induced >1.5 fold in our 
analysis.  We found that 20 of the 49 genes were regulated in a non-tissue specific 
manner, as their expression levels increased in any tissue lacking E2f7/E2f8 (Figure 8a). 
We classified the other 29 genes as placenta-specific targets, considering they were not 
upregulated in the fetus.  Promoter analysis on TFSearch indicated that 85% of the 20 
gene subset (17/20) featured conserved E2F binding sites on their promoters, suggesting 
an enrichment of E2F target genes in this set. On the other hand, only ~10% of the 
placenta-specific genes contained E2F binding sites on their promoters, indicating that 
they are likely regulated indirectly or through atypical binding sites. 
 We then performed a series of chromatin immunoprecipitations (ChIP) to 
determine which genes from the 20 gene set were truly direct targets of E2F7 and E2F8.  
Because reliable mouse E2F7/E2F8-specific ChIP-grade antibodies are not available, we 
overexpressed flag-tagged E2F7/E2F8 in human embryonic kidney cells (HEK 293) and 
performed ChIP assays with flag-specific antibodies.  We tested nine different promoters, 
focusing on regions that contained consensus E2F binding sites, and found that anti-flag 
antibody efficiently co-immunoprecipitated all nine promoter sequences (Figure 8b).  
Control IgG antibodies did not immunoprecipitate target sequences, and flag antibodies 
did not immunoprecipitate irrelevant sequences in E2f1 (exon 1) or on the tubulin 
promoter.  From these results, we conclude that these 20 genes are bona fide targets of 
E2F7 and E2F8 in vivo.  Interestingly, these 20 targets encode genes involved in cell 
cycle regulation (Figure 9).  The 29 placenta-specific genes encoded proteins involved 
metabolism and placenta development (Figure 10). 
  
 
Loss of E2f7/E2f8 results in ectopic DNA replication 
The high percentage of cell cycle related direct targets prompted us to examine the E2f7-/-
/E2f8-/- placentas for cell cycle defects.  To this end, we measured DNA synthesis via 
BrdU incorporation in each of the three major extra-embryonic cell lineages.  Our 
analysis revealed ectopic replication in both the TG and ST lineages, but not in the LT 
lineage (Figures 11a and 11b).  We then asked whether this ectopic DNA replication is 
also present in the embryonic compartment.  However, fetal tissue during mid-gestation 
undergoes such high endogenous levels DNA replication that ectopic replication cannot 
be detected.  Therefore, we decided to obtain more differentiated tissue from the lung of 
Sox2-cre pups at P0.  We again noticed ectopic DNA replication in Sox2-cre pups 
(Figures 11c and 11d).  These findings together strongly suggest that E2F7 and E2F8 
play a novel role in regulating the G1/S checkpoint in a tissue non-specific manner.  
 
Loss of E2F3a Rescued Placental Defects and Lethality of E2f7 and E2f8 Double 
Mutant Embryos 
Knowing that E2F7 and E2F8 play a critical role in regulating the G1/S checkpoint, we 
wanted to further characterize its function in regulating cell progression into S phase.  
Our analysis of the G1/S-specific targets then led us to consider E2F3a, which is known 
to regulate many of the same targets.  E2F3a serves as a potent transcription activator, 
and functions in stimulating the cell through G1 and into S phase (Danielian et al., 2008; 
Chong et al., 2009).  We hypothesized then that the loss E2F7 and E2F8 would lead to an 
increase in E2F3a activity at the G1/S checkpoint, resulting in ectopic DNA replication.  
  
If E2F3a was indeed overactive in the absence of E2F7/E2F8, then the additional deletion 
of E2f3a in double knockout mice might rescue the ectopic DNA replication.  We 
therefore proceeded to breed E2f7+/-/E2f8-/- mice to E2f3a-/- mice to obtain E2f3a+/-
/E2f7+/-/E2f8+/- offspring.  We then crossed these offspring to obtain                          
E2f3a-/-/E2f7-/-/E2f8-/- (Triple Knockout; TKO) embryos.  Amazingly, all TKO offspring 
were viable at E11.5, and some even survived to term, dying shortly after birth (Figure 
12a).  Analysis of H&E staining of the E10.5 placenta showed that the additional deletion 
of E2f3a fully restored the structure and vascular network of the placenta (Figure 12b).  
From these results, we are convinced that the increase in E2F3a function is the leading 
cause of placental dysfunction and mid-gestation lethality. 
 To address the well known role of E2F3a in stimulating DNA replication, we then 
asked whether the ablation of E2f3a would rescue the ectopic DNA synthesis observed in 
E2f7-/-/E2f8-/- placentas.  We measured DNA synthesis in both the ST and TG lineages of 
the placenta.  The analysis revealed a full rescue of the ectopic DNA synthesis in the 
E2f3a-/-/E2f7-/-/E2f8-/- placentas (Figure 11c).  These results taken together indicate that 
an increase in E2F3a activity is the cause of ectopic DNA synthesis observed in E2f7-/-
/E2f8-/- placentas, and that this aberrant DNA synthesis is the major contributor to 
placental dysfunction.  We conclude then that E2F7 and E2F8 play a critical role in 
regulating the progression from G1 to S phase, and that the ectopic S phase entry in   
E2f7-/-/E2f8-/- placentas is the leading contributor to mid-gestation lethality. 
 
 
 
  
Loss of E2f7/E2f8 Results in Aberrant Mitosis in Trophoblast Giant Cells 
Although the ectopic DNA replication is the leading contributor to embryonic we had 
already analyzed the role E2F7/E2F8 at the G1/S transition, we next asked whether it also 
played a role at the G2/M checkpoint. To this end, I determined the percentage of cells 
undergoing mitosis via IHC staining with antibodies specific for phosho-Histone 3 (p-
H3) (Figure 13a).  Our analysis revealed a significant induction in TG cells, but not in ST 
or LT lineages (Figure 13b).  This result was particularly surprising in that TG cells do 
not perform a typical cell cycle, but instead undergo repeated rounds of DNA replication 
with no mitosis, known as the endocycle.  Because the departure from an endocycle into 
a typical cell cycle is such a unique phenotype, we sought to visualize this phenomenon. 
For this purpose, we performed a Draq-5 stain then utilized Confocal microscopy, giving 
us 3D renderings of the nuclei (Figure 13c). Surprisingly, these images indicated that the 
E2f7/E2f8 deficient Trophoblast Giant cells were not undergoing normal mitoses. Instead, 
they underwent karyokinesis without cytokinesis, producing multi-nucleated cells, which 
we confirmed using electron microscopy (Figure 13d).  A significant induction in 
multinucleated giant cells was observed in E2f7-/-/E2f8-/- placentas (Figure 13e).  Though 
the mechanism behind this unusual mitosis remains unclear, we hypothesize that the 
APC/C required for cytokinesis is regulated through a different pathway, and is therefore 
is not susceptible to E2f7/E2f8 deficiency. 
 We then asked whether the ectopic karyokinesis would be rescued by the 
additional ablation of E2f3a.  Analysis of p-H3 staining showed that there was no rescue 
of the mitotic phenotype, and multinucleated giant cells were still present in the placenta 
(Data not shown).  This result indicates that although E2F7 and E2F8 are critical in 
  
regulating both the G1/S and G2/M transitions, these transitions are not connected, as the 
rescue of ectopic DNA replication does not result in the rescue of ectopic M phase entry.  
This also serves to confirm our conclusion that aberrant S phase entry is the leading 
contributor to placental dysfunction and embryonic lethality. 
 
E2F7/E2F8 Work in Concert with Rb and Related Pocket Proteins 
While investigating the functional role of E2F7/E2F8 in regulating cell cycle progression, 
we were also examining the genetic link between E2F7/E2F8 and pRb/p107/p130 (pocket 
protein family).  It is well documented that the interactions between the E2f family and 
pocket protein family are critical for the proper cell cycle progression.  However, the 
mechanism through which the pocket proteins bind DNA remains unknown.  Because   
Rb-/- embryos bear a high resemblance to E2f7-/-/E2f8-/-, we hypothesized that E2F7 and 
E2F8 could act as the critical downstream binding partners for pRb.  Rb-/- mice show 
severe placental defects, resulting in embryonic lethality (Wu et al, 2003).  Also, pRb 
function in the placenta is both necessary and sufficient to carry an embryo to term 
(Wenzel et al, 2007).  The only major difference observed between Rb-/- and E2f7-/-/E2f8-
/-
 embryos is the exact time point of lethality, with E2f7-/-/E2f8-/- embryos dying by E11.5 
and Rb-/- embryos dying between E13.5 and E16.5.  
 I then aimed to determine the reason for the discrepancy between the lethality 
time points.  We hypothesized that the Rb-/- mice survived longer due to compensation 
from the other pocket proteins, p107 and p130.  We therefore crossed Rb+/-/p107+/- with         
Rb+/-/p107+/- and Rb+/-/p130+/- with Rb+/-/p130+/- to obtain Rb-/-/p107-/- and Rb-/-/p130-/- 
embryos, respectively.  Genotyping analysis revealed that the additional ablation of p130 
  
had no effect on the time of embryonic lethality, but preliminary data indicates that      
Rb-/-/p107-/- embryos die at a similar time point as E2f7-/-/E2f8-/- embryos (Figure 14a and 
14b).  We therefore hypothesize that p107 is the other pocket protein that interacts with 
E2F7/E2F8. 
 Continuing our investigation into the nature of the genetic interaction between 
E2F7/E2F8 and Rb/p107, we decided to set up breedings between the two genetic groups 
in order to obtain pups that were heterozygous for each of the four genes.  I hypothesized 
that if these four proteins function cooperatively, then the loss of one allele per gene may 
produce an observable phenotype.  However, these mice were viable both at birth (P0) 
and 21 days post birth (P21) at the predicted Mendelian ratios.  We then bred mice to 
obtain E2f7+/-/E2f8-/-Rb+/-/p107+/- or   E2f7-/-/E2f8+/-Rb+/-/p107+/- pups, containing one 
fewer allele than the previously described quadruple heterozygous mice.  Our early 
results indicate that losing an additional allele of either E2f7 or E2f8 results in decreased 
viability, as these mice survive to P21 at a lower rate than Mendelian ratios would predict 
(Figure 15).  We then analyzed viability at P0, and found viable E2f7-/-/E2f8+/-Rb+/-
/p107+/- pups at nearly Mendelian ratios, whereas E2f7+/-/E2f8-/-Rb+/-/p107+/- pups were 
viable at below expected numbers. If these results prove significant, they would serve to 
bolster the claim that E2F7 and E2F8 work in concert with pRb and p107.  
 
Discussion 
Conclusion 
E2F7 and E2F8 constitute the most recently discovered, and therefore the least 
understood branch of the E2F family.  In this study, we show that E2F7/E2F8 play a 
  
critical role in maintaining the integrity of the extra-embryonic compartment during mid-
gestation.  This significance was demonstrated by a conditional knockout study that 
showed their activity in the placenta is both necessary and sufficient to carry embryos to 
term.  Our analysis of global gene expression arrays in placental and fetal tissues then 
illuminated a unique transcriptional network regulated by E2F7 and E2F8.  This 
transcriptional network proved critical in regulating the transition through the G1/S 
checkpoint and suppressing mitotic entry in the endocycle.  While disruption of this 
network was tolerated by E2f7-/-/E2f8-/- embryos, it had catastrophic consequences in the 
spongiotrophoblast and trophoblast giant cells of the placenta, resulting in ectopic DNA 
replication and aberrant karyokinesis in giant cells.  Together, these data provide 
convincing evidence for E2F7/E2F8-mediated control of mammalian cell cycle 
progression. 
 
Future Direction 
This study has made a significant contribution in defining the molecular role of E2F7 and 
E2F8 in embryonic development, but work still remains in illuminating their biological 
functions and molecular interactions.  Our priority right now is to further define the 
physical interaction between E2F7/E2F8 and E2F3a at the G1/S checkpoint.  While we 
conclude that this interaction is critical for proper S phase entry, the nature of the 
interaction remains unclear.  We are currently investigating the possibility of a 
competitive interaction at target promoters by performing a series of ChIP experiments in 
MEFs, to determine if E2F3a binds its target promoters at a higher rate in the absence of 
E2F7/E2F8.  This analysis could reveal a novel interaction within the E2f family, as 
  
members of the family have never before been observed to undergo competitive 
interactions as a mechanism of regulating cell cycle. 
The newly discovered connection with E2F3a will likely carry important medical 
implications for E2F7 and E2F8 as well. E2F3a is noted to be upregulated in several 
forms of cancer, including prostate and bladder (Paulson et al., 2006). This is the result of 
an increase rate of cellular proliferation and an override of proper checkpoints transitions. 
This link, along with the already well established connection between the E2F family and 
cell cycle control, indicates a strong likelihood that E2F7 and E2F8 will be points of 
interest in future cancer studies. 
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Schematic representations of E2F transcription factors. Eight distinct E2F gene loci encode for
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E2F7 and E2F8 express highly in the placenta (A) Real-time RT-PCR analysis of E2f7 or
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Immunohistochemistry using antibodies specific against E2F7 (top panels) and E2F8 (bottom
panels) on E10.5 placenta sections with the indicated genotypes. Positive trophoblast giant
cells are indicated by arrows.
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with the indicated genotypes were stained with Hematoxylin and Eosin (H&E). The
bottom panels are high magnification images of representative areas demarcated by the
boxes in the top panels. De., Decidua; La., Labyrinth. (B) Real-time RT-PCR analysis of
trophoblast cell lineage markers in E10.5 E2f7+/+E2f8+/+ (7+/+8+/+, black) and
E2f7-/-E2f8-/- (7-/-8-/-, red) placentas. TS, trophoblast stem cells; SP, spongiotrophoblast
cells; TG, trophoblast giant cells. (C) RNA in situ hybridization analysis of Proliferin, a
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Immunofluorescence staining of E10.5 placenta sections with the indicated genotypes,
using antibodies specific for Placental Lactogen 1 (PL-1), a giant cell-specific marker.
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E2F7/E2F8-dependent Gene Expression in the Placenta. (A) Dendogram of unsupervised
clustering analysis using centered correlation and average linkage. E10.5 placentas with the
indicated genotypes were presented individually. Note the segregation of these placentas based on
their genotypes. (B) Potential direct targets of E2F7 and E2F8 in placenta are presented by a two-
set Venn diagram. Genes differentially upregulated in E2f7-/- ;E2f8-/- and Cyp19-cre placentas
with >2-fold (p<0.05) (C) Pie chart describing major gene ontology categories of 49 differentially
expressed genes shown in Figure 7B
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Identification of E2F7/E2F8 direct targets (A) ) Left: potential E2F7 and E2F8 direct targets
are presented by a three-set Venn diagram. Genes differentially upregulated in E2f7-/-;E2f8-/-
and Cyp19-cre placentas with >2-fold (p<0.05) and in Sox2-cre fetuses with >1.6-fold (p<0.05)
are shown as colored circles. Note that the overlapping area of all data sets contains 20 genes
which are upregulated in a cell type-independent manner. Other 29 genes (26 annotated and 3
non-annotated) overlapped by only E2f7-/-;E2f8-/- and Cyp19-cre data sets are upregulated in a
placenta-specific manner. Right: promoter analysis of the groups of 20 and 29 genes. The
defined mouse and human promoter regions (-1000bp ~ +300bp) were examined for consensus
E2F binding sites. Results are represented as a fraction and a percentage of genes that have at
least one E2F binding site conserved between mice and humans (Conserved). (B) ) Confirmation
of promoter occupancy by E2F7 and E2F8 in HEK293 cells overexpressing flag-tagged E2F7 or
E2F8 wild type (w), flag-tagged E2F7 or E2F8 DNA binding mutant (m) using a standard ChIP
protocol. Normal mouse IgG was used as a negative control. Immunoprecipitates were
amplified with primers specific to the E2F binding sites in promoters of the indicated genes,
irrelevant sequences in the tubulin promoter (Tub) and in the E2f1 coding region (E2f1ds). Real-
time PCR was performed in triplicate and cycle numbers were normalized to 1% of the input.
Error bars represent standard deviations.
Figure 9
Gene symbol Function
E2F sites
(mouse)
E2F sites
(human)
Conserved 
Sites
2810417H13Rik (Paf) PCNA-associated factor (p15PAF), oncogene, DNA replication 3 3 2
Cdc6 DNA replication 3 2 2
Zfp367 unknown 3 2 2
Dtl (Cdt2) G2/M checkpoint 2 2 2
E2f1 G1 to S progression, apoptosis 2 2 2
Mcm4 DNA replication, transcription 4 3 1
Uhrf1 (ICBP90) DNA repair, ubiquitin cycle, cell cycle 4 4 1
Mcm5 DNA replication, transcription 3 2 1
2600005O03Rik (Dscc1)
defective in sister chromatid cohesion homolog, cell cycle, DNA 
replication 2 2 1
Fbxl20 ubiquitin cycle 2 2 1
Chek1
G2/M transition, DNA damamge, DNA repair, meiotic 
recombination 1 4 1
Mcm10 DNA replication, G2/M checkpoints, 1 3 1
Gins2 DNA replication 3 1 0
Mcm6 DNA replication, transcription 3 3 0
Bard1 transcription, cell cycle, DNA damage, DNA repair, apoptosis 2 1 0
20 potential direct targets of E2F7 and E2F8
Ccdc59 regulation of transcription, DNA-dependent 1 0 0
Tacstd1 defense response 1 2 0
Cdc45l cell cycle, DNA replication, cell division 0 1 0
Asb7 intracellular signaling cascade? 0 1 0
Ung DNA base-excision repair 0 3 0
20 Direct Targets of E2F7 and E2F8. 
Classification of tissue non-specific, direct targets of E2F7 and E2F8. E2F sites indicates number of 
consensus E2F binding sites between -1000bp and 300bp (promoter region)
Figure 10
Gene symbol Function
E2F sites
(mouse)
E2F sites
(human)
Conserved
sites
Hells
chromatin silencing,  centric heterochromatin formation, 
mitosis, apoptosis 2 3 2
Phf19 regulation of transcription 4 3 1
Fbxo2 ubiquitin cycle, proteolysis 3 1 0
Srd5a1 androgen biosynthesis 3 2 0
Ak3l1 /// LOC100047616
nucleobase, nucleoside, nucleotide and nucleic acid 
metabolism 2 2 0
Trpm5 ion transport 2 0 0
Cdkn1a (p21) cell cycle etc. 1 0 0
Egln3 oxygen sensor, HIF-PH3 1 3 0
Elf5 ectoderm development, transcription, EST family 1 0 0
Plxnb2 positive regulation of axonogenesis 1 2 0
Pthlh cell proliferation, cAMP metabolism, development 1 0 0
Slco5a1 transport activity 1 1 0
Timp1 cell proliferation, erythrocyte maturation (x-chromosome) 1 1 0
5830482F20Rik unknown 0 0 0
Aplp1
regulation of translation, extracellular matrix organization 
and biogenesis 0 1 0
Ceacam1 neovascularization, cell adhesion 0 2 0
Dll4 activates Notch, angiogenesis 0 2 0
29 targets without E2F binding site
Ecm1 extracellular matrix, transport 0 0 0
Fasl cell death 0 0 0
Ifi30 unknown 0 0 0
Irx1 transcription, development 0 3 0
Klk1b22 /// Klk1b9 proteolysis 0 0 0
LOC100040854 /// 
LOC100040861 /// 
OTTMUSG00000010207 unknown 0 n/a 0
Myh6 muscle contraction 0 1 0
Pfpl invasive trophoblast giant cells 0 n/a 0
Rpgrip1 eye photoreceptor cell development, response to stimulus 0 0 0
BC062258 could not find n/a n/a n/a
D13Ertd608e could not find n/a n/a n/a
EG627488 /// EG667692 /// 
EG667695 /// LOC100043292 could not find n/a n/a n/a
29 Placenta-Specific Targets of E2F7 and E2F8. 
Classification of placenta-specific targets of  E2F7 and E2F8. E2F sites indicates number of 
consensus E2F binding sites between -1000bp and 300bp (promoter region)
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Deletion of E2f7/E2f8 leads to ectopic DNA synthesis (A )Left: Merge images of
immunofluorescence BrdU/PL-1 double staining on E10.5 placenta. Scale bars, 100 µm.
(B) Percentages of BrdU positive cells were quantified for the indicated trophoblast cell types
(TG, trophoblast giant cells; SP, spongiotrophoblasts; LT, labyrinth trophoblasts). Data are
represented as the average ± SD percentage of positive cells. n, number of placenta samples
analyzed for each genetic group Pairwise comparisons were evaluated by two-tailed Student’s t-
tests (** p<0.006). (C) ) Immunohistochemistry using antibodies specific against BrdU in P0
lung. (D) Percentages of BrdU positive cells were quantified. Percentages were analyzed and
compared as described above
Figure 12
E10.5                     - 9                                   23(1)                   118
Table: Genotypic analysis of embryos during development: E2f3a/E2f7/E2f8 crosses
E2F3a+/+ total
() number of dead embryos; Exact binomial test:  a highly significant (p<0.0007)
E2f7-/-E2f8-/- E2f7-/-E2f8-/-
E2f3a+/- E2f3a-/-
E2f7-/-E2f8-/-
E14.5                     - - 6(2)a 57
expected                       - 10                                           20
expected                       - - 10
P0                          - 0                                    2(1)                     37  
expected                       - 3                                              5      
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Loss of E2f3a rescues embryonic lethality in E2f7/E2f8 double mutant embryos (A) Genotypic
analysis of embryos derived from the E2f3a/E2f7/E2f8 crosses at the indicated stages of development.
(B) H&E staining of E10.5 placentas with the indicated genotypes. Note that the triple knockout
placenta bears a high resemblance to the wild type placenta (C) Percentages of BrdU and P-H3
positive cells were quantified for the indicated trophoblast cell types (TG, trophoblast giant cells; SP,
spongiotrophoblasts) in E10.5 placentas. Data are represented as the average ± SD percentage of
positive cells. n, number of placenta samples analyzed for each genetic group Pairwise comparisons
were evaluated by two-tailed Student’s t-tests (** p<0.006).
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Loss of E2f7/E2f8 Results in Aberrant Mitosis in Trophoblast Giant Cells
(A) Immunohistochemistry using antibodies specific against Phospho-Histone 3 on E10.5
placenta sections with the indicated genotypes. Positive trophoblast giant cells are indicated by
arrows (B) Percentages of P-H3 positive cells were quantified for the indicated trophoblast cell
types (TG, trophoblast giant cells; SP, spongiotrophoblasts; LT, labyrinth trophoblast) in E10.5
placentas. Data are represented as the average ± SD percentage of positive cells. n, number of
placenta samples analyzed for each genetic group Pairwise comparisons were evaluated by two-
tailed Student’s t-tests (** p<0.006). (C) Top Panels: Draq5 Immunoflourescent staining of
E10.5 placenta. Scale Bars, 100µm. Bottom Panel: 3D rendering of E2f7-/-E2f8-/- Giant Cell.
Each color represents distinct nucleus. Notice close proximity and tight fit, indicating recent
karyokinesis. (D) Scanning Electron Microscopic image of E2f7-/-E2f8-/- E10.5 placenta. Top
Panel: Dotted line marks cell membrane. Distinct nuclei are indicated by arrows. Bottom Panel:
close up view of top panel. N.E., nuclear envelope. Notice two distinct nuclei within one cell
membrane. (E) Percentages of binuclead cells were quantified for trophoblast giant cells (TG)
in E10.5 placentas. Data are represented as the average ± SD percentage of binucleated cells. n,
number of placenta samples analyzed for each genetic group Pairwise comparisons were
evaluated by two-tailed Student’s t-tests (** p<0.006).
expected 6                12           7                          11              25             14                          6        12              7
expected                   7               13         7                          13              26              13                  7               13              7 
total
E12.5                 4(1)          9     7               5         29(2)    16(3)               2(1)      9(5)      3(2)             98
E13.5                6(1)         16 0  18(2)     27 7 5(3) 4(8) 3(4) 105
Genotypic analysis of embryos during development: Rb-p130
p130+/+ p130-/-p130+/-
() number of dead embryos recovered; Exact binomial test:  a significant (p=xxxxx), b highly significant (p<xxxxx).
p130+/+ p130-/-p130+/- p130+/+ p130-/-p130+/-
Rb+/+ Rb+/- Rb-/-
E11.5                  1     1       2(1)        1(1)         3           4                 3  1 0                18
E10.5                   2            9       4                10 18(7)     13   4   12       7(2)             88
Genotypic analysis of embryos during development: Rb/p107 crosses
p107+/+ p107-/-p107+/-
() number of dead embryos recovered; Exact binomial test:  a significant (p=0.0015), b highly significant (p<0.0007).
p107+/+ p107-/-p107+/- p107+/+ p107-/-p107+/-
Rb+/+ Rb+/- Rb-/-
expected                    6               11           6                          11             22              11        6                11           6
expected                   1                2             1                           2             4               2                         1          2              1
total
A
B
Figure 14
Knockout of Rb/p107 recapitulates the E2f7/E2f8 lethality timepoint (A) Genotypic 
analysis of embryos derived from the Rb/p107 crosses at the indicated stages of development. 
(B) Genotypic analysis of embryos derived from the Rb/p130 crosses at the indicated stages of 
development
Genotypic analysis of embryos during development: E2f7/E2f8/Rb/p107 crosses
total
Rb+/-p107+/-
P0                 7(1)                          6                         5                         4(1)                    1(1)               121
P21                20                            7                         1                           9                     1                 230           
E2f7-/-E2f8+/-
expected                   6                                          4                                     4                5                                     5      
expected                  15                                         6                                     6                 7                                     7
() number of dead embryos; Exact binomial test:  a highly significant (p< 0.0001).
E2f7+/-E2f8+/-
Rb+/+p107+/- Rb+/-p107+/-
E2f7+/-E2f8-/-
Rb+/+p107+/- Rb+/-p107+/-
E2f7/E2f8 share a prominent genetic interaction with Rb/p107.       Genotypic analysis of 
embryos derived from the E2f7/E2f8/Rb/p107 crosses at the indicated stages of development   
Figure 15
